Management of Arterial Complications after Living Donor Liver Transplantation

Abstract

iver transplantation is perceived as the only curative treatment for patients with end-stage liver disease. Approximately 20-25% of patients with liver failure die while waiting for a liver transplant, and another 20-30% of patients with hepatocellular carcinoma drop off the waiting list because of tumor progression. It is a retrospective study in which preoperative data, operative data and post operative data were collected for 293 patients who underwent LDLT from 2008 to 2017at (ASCOT). One patient was excluded as he died intraoperative. In this study 16 (5.5%) patients developed arterial complications divided into two groups:11 patients with early complications (within one month from the operation) and and 5patients with late complications.